|
1. |
Immune Modulating Effects of Low Doses of Cyclophosphamide and Keyhole Limpet Hemocyanine on Peripheral Blood Immune Parameters in Patients with Metastatic Renal Cell Carcinoma |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 1-8
S. Kleinknecht,
K.-H. Bichler,
W.L. Strohmaier,
Preview
|
PDF (1650KB)
|
|
摘要:
Assessing the peripheral blood immune status, we had found evidence of immunosuppression in metastatic renal cell carcinoma. Since immunosuppression might interfere with the outcome of immunotherapy, it was submitted to further investigation. Immunosuppression can be mediated by T suppressor cells, which for their part are inhibited by low-dose cyclophosphamide (Cy). We tested whether the immunomodulating effects of the biological response modifier keyhole limpet hemocyanine (KLH) on cellular and humoral immune parameters would be intensified by low-dose Cy. 10 patients were given 300 mg/m2 Cy i.v. 3 days before application of 1 mg KLH i.m. up to 8 times in 4-weekly intervals. Immune parameters were assayed twice pretherapeutically, and prior to and 1 day and 1 week after each KLH injection. In contrast to the results obtained with KLH-monoapplication, lymphocyte subsets – with the exception of T4 cell counts and the T4/T8 ratio – remained stable during the first 4 months of observation. There were increases in immunoglobulines and in the immunoactivation markers tumor necrosis factor, neopterin and β2-microglobulin. The tendencies found here differed from those found in a previous study on patients who were given KLH alone, and were similar to those found in patients with nonmetastatic disease who received KLH alone. However, the increases of the activation markers during KLH + Cy application were at best half as much as in patients with nonmetastatic disease. In conclusion, immunosuppression was influenced, but not counterbalanced by low-dose Cy. Most probably other mediators of immunosuppression than T suppressor cells, for example prostaglan-din E2, must be considered as well. Treatment of immunosuppression, however, seems to be a promising concept for improving the clinical results of immunotherapy.
ISSN:0042-1138
DOI:10.1159/000282287
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
2. |
ABO and Rhesus Blood Groups as Prognostic Factors in Transitional Cell Carcinomas of the Upper Urinary Tract |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 9-13
John Krogh,
Ebbe Kvist,
Preview
|
PDF (1712KB)
|
|
摘要:
In a study of 290 patients with transitional cell carcinoma of the upper urinary tract an excess of blood group A was found. Comparisons between blood group A versus·and rhesus-positive versus rhesus-negative in relation to tumor stages or grades of dysplasia showed no significant differences neither at presentation nor in actuarial survival rates. It is concluded that the blood group systems ABO and rhesus have no prognostic value in urothelial tumors of the upper urinary tract.
ISSN:0042-1138
DOI:10.1159/000282288
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
3. |
Behavior of Epithelial Differentiation Antigens (Carcinoembryonic Antigen, Epithelial Membrane Antigen, Keratin and Cytokeratin) in Transitional Cell Carcinomas of the Bladder |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 14-19
Sá;nchez-Ferná;ndez de Sevilla,
L. Morell-Quadreny,
M. Gil-Salom,
M. Pérez-Bacete,
B. Fenollosa-Entrena,
A. Llombart-Bosch,
Preview
|
PDF (2648KB)
|
|
摘要:
Results of an immunohistochemical study in normal urothelium and transitional cell carcinomas of the bladder are presented. Paraffin-embedded material was confronted with immunoantisera against carcinoembryonic antigen (CEA), keratin (K), cytokeratin (CK) and epithelial membrane antigen (EMA). Immunohistochemical findings confirm the changes in reactivity of dysplastic urothelium and carcinoma in situ for CEA, CK and EMA, in comparison with normal urothelium. Statistically significant differences were also found, depending upon tumor stage, in staining of transitional cell carcinomas for K and CK. Expression of CK correlated with the tumor differentiation grade: normal urothelium and well-differentiated carcinomas showed a specific pattern of immunostaining for the basal cells, this pattern being lost in poorly differentiated carcinomas.
ISSN:0042-1138
DOI:10.1159/000282289
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
4. |
Glycolipid Expression in Prostatic Tissue and Analysis of the Antigen Recognized by Antiprostatic Monoclonal Antibody APG1 |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 20-24
Makoto Satoh,
Yasuo Fukushi,
Sadafumi Kawamura,
Chikara Ohyama,
Seiichi Saito,
Seiichi Orikasa,
Edward Nudleman,
Sen-itiroh Hakamori,
Preview
|
PDF (1918KB)
|
|
摘要:
The expression patterns of glycolipid from prostatic hyperplasia, prostatic cancer and normal prostate tissue were observed. A further analysis of antigen recognized by mouse monoclonal antibody APG1, which was gained by immunizing glycolipids extracted from human prostate cancer, was also performed. In cancer tissue, both of the lactosyl and globoside series glycolipids were found to be generally reduced, although in the ganglioside series, GM3 and GD3 were not reduced and only the glycolipids with longer chains than GD2 were found to be reduced. These results indicated that the inhibition of sugar chain elongation, but not sialylation, was the main synthetic change occurring with carcinogenesis of the human prostate. APG1 reacted with only two bands near GM2 and GD2 of the ganglioside fraction on a thin-layer chromatography plate, but it did not react with any of the known gangliosides of the ganglioside series including GM2 and GD2. Histochemically, APG1 showed intense reaction only in frozen tissue sections of human prostate, and the reactivity decreased with the increasing grade of cancer. Therefore, this antigen was considered to be a prostate-specific and differentiated antigen reacting with nonganglioseries gangliosides.
ISSN:0042-1138
DOI:10.1159/000282290
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
5. |
Calcification in Human Osteoblasts Cultured in Medium Conditioned by the Prostatic Cancer Cell Line PC-3 and Prostatic Acid Phosphatase |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 25-30
Go Kimura,
Yuichi Sugisaki,
Yozo Masugi,
Nando Nakazawa,
Preview
|
PDF (2535KB)
|
|
摘要:
A medium that had been conditioned by PC-3 cells stimulated the calcification of a human osteoblastic cell line, Tak-10, in a nonmitogenic culture. The calcification of the osteoblasts was stimulated maximally at a 25% concentration of the conditioned medium. Calcification activity was markedly enhanced by the addition of both prostatic acid phosphatase (PAP) and its substrate, α-glycerophosphate, to the medium; however, PAP added alone did not enhance this activity. These results suggest that human prostatic carcinoma cells produce a factor that stimulates the calcification of the human osteoblasts. Results have also suggested that PAP is a requisite for osteogenesis provided that its substrates are abundant in the medium.
ISSN:0042-1138
DOI:10.1159/000282291
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
6. |
Peptidergic Innervation of the Normal and Obstructed Human Pyeloureteral Junctions |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 31-34
H. Tainio,
T. Kylmälä,
A. Heikkinen,
Preview
|
PDF (1596KB)
|
|
摘要:
The neuropeptidergic innervation of the normal and obstructed human pyeloureteral junction was investigated using immunohistochemical techniques. A dense innervation of neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP) in the intrinsic obstruction type was demonstrated. NPY and VIP formed networks in the muscular layer. NPY was also found in perivascular plexuses and VIP adjacent to the epithelium. Calcitonin gene-related peptide, galanin and substance P nerves were also seen in the muscular layer, although sparsely. It is proposed that NPY and VIP have a role in the pathophysiology of the intrinsic obstruction type of the human pyeloureteral junction. The innervation pattern of the junction with the external type of obstruction was similar to that of the normal pyeloureteral junction.
ISSN:0042-1138
DOI:10.1159/000282292
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
7. |
Relaxant Effect of Thiphenamil HCI on Upper Urinary Tract Frequency of Contraction of Healthy Asymptomatic Volunteers |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 35-38
C.E. Constantinou,
Preview
|
PDF (1436KB)
|
|
摘要:
The pharmacologic effect of thiphenamil HCI on the upper urinary tract as a relaxant of renal pelvic contractions was studied. A total of 17 subjects with no known upper urinary tract abnormalities were scanned. A Diasonics ultrasound scanner at 3.5 MHz was used to visualize the kidney and renal pelvis with the subject in the supine position. Control recordings of renal pelvic and calyceal contractility were made on videotape for approximately 30 min. The subject was then given a single dose of 400 mg thiphenamil HCI and visualization of contractility continued for approximately 60-90 min. Criteria for the evaluation of the data were the mean frequency of pelvic contraction cross-section of the pelvis, and velocity and direction contraction. Ultrasonic images were filtered by a video filtering process and averaged using the digital conversion and summation in real time. The results show that under control conditions renal pelvic contractions are at a frequency of 2 ± 1.8 min-1. Contractions are initiated with the intrarenal pelvis and continue towards the ureter at a rate of 1.3 ± 0.8 cm/s. Following thiphenamil HCI, there is a significant reduction in pelvic contraction frequency, 0.6 ± 0.6 πikr’, and the opposing walls of the renal pelvis do not completely close in the formation of a bolus. The results obtained from this study demonstrate that thiphenamil suppresses upper urinary tract contractility. As a consequence of this observation, it is postulated that this agent may be of use in the acute relaxation of the upper urinary tract for renal colic and stone management.
ISSN:0042-1138
DOI:10.1159/000282293
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
8. |
Importance of the Active Component of the Detrusor Muscle in Bladder Compliance |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 39-41
J. Salinas,
M. Virseda,
F. Mellado,
M.P. Fuente,
A.C. Uson,
Preview
|
PDF (1301KB)
|
|
摘要:
An appropiate experimental study was designed and carried out in mongrel dogs, in order to evaluate the active muscle and cholinergic participation on bladder compliance. The filling bladder pressure was measured at 100 ml of bladder volume, in 50 dogs distributed into five groups of 10 dogs each: (1) control group, (2) group which received atropine (cholinergic antagonist), (3) group which received verapamil (extracellular Ca2+ blocker), (4) group which received nitroprusside (intracellular Ca2+ antagonist), and (5) group which received EGTA (Ca2+-chelating agent). Furthermore, the following was demonstrated. (1) The greatest decrease of the bladder filling pressure was observed in the group which was treated with EGTA. (2) A significant decrease of the bladder filling pressure was also seen in the group which was given nitroprusside. (3) The decrease of bladder filling pressure in the verapamil group tended towards statistical significance. (4) There was no decrease in the atropine group. Thus, it was concluded that the active muscle component has an important role in the bladder compliance (through the intracellular calcium fraction), and the cholinergic component does not participate in the bladder compliance.
ISSN:0042-1138
DOI:10.1159/000282294
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
9. |
Pharmacologic Treatment of Detrusor Incontinence with Thiphenamil HCI |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 42-47
C.E. Constantinou,
Preview
|
PDF (2500KB)
|
|
摘要:
A controlled double-blind crossover study is reported in which quantitative urodynamic data and qualitative information are combined to evaluate the treatment of detrusor incontinence using thiphenamil HCI in patients with detrusor instability. Patients placed on the treatment protocol were randomized to placebo or thiphenamil 400 mg q.i.d. Two weeks of thiphenamil HCI or placebo administration were followed by 1 week of washout followed by a cross-over to an additional 2 weeks of placebo or thiphenamil HCI administration. Of the 23 patients 7 dropped out at various stages of the study. The mean age of patients studied was 44 ± 14 years old. Throughout the study, patients were asked to complete a formalized diary card of the amount and time of voiding and the incidence of incontinence. Three urodynamics studies were done in the following sequence: pretreatment, postwashout, and posttreatment. Parameters of bladder capacity, sensations, stability and pressure/flow were obtained. In addition, resting urethral closure pressures were recorded. The results show that the frequency of incontinence, which was based on the patients’ responses, decreased significantly (0.01 < p < 0.025). There was an insignificant decrease in the number of voidings and increase in the amount voided each time. Patients on thiphenamil reported that their pads were significantly drier from baseline (p = 0.01). In response to questions comparing problems caused by urine loss during baseline and thiphenamil treatment, analysis shows a significant decrease of problems due to loss of urine (p = 0.01) when the patient was taking the drug compared to the placebo. Evaluation of urodynamic parameters shows a significant reduction in detrusor voiding pressure from 46.1 ± 25.3 to 31.9 ± 14.1 (p = 0.05). No significant changes were observed in the flow rate, capacity, urethral resting or opening pressure or bladder work. Residual volume during urodynamics was lower on thiphenamil HCI but this difference was marginally significant. It is concluded that patients reported that thiphenamil HCI produced a significant decrease in their frequency and amount of incontinence. This conclusion is based on the documentation available in the diary cards and questionnaire. The urodynamic studies do not, as a whole, reflect an objective numerical improvement in many of the parameters considered.
ISSN:0042-1138
DOI:10.1159/000282295
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
10. |
Perineal Pudendal Neurotomy versus Selective Neurotomy of the S2 Somatic Contribution to the Pudendal Nerve |
|
Urologia Internationalis,
Volume 48,
Issue 1,
1992,
Page 48-52
Ruud J.L.H. Bosch,
François Benard,
Sherif R. Aboseif,
Richard A. Schmidt,
Emil A. Tanagho,
Preview
|
PDF (2342KB)
|
|
摘要:
In 10 dogs that underwent bilateral electrode implantation on the S2 ventral root, 5 then underwent a bilateral total perineal neurotomy of the pudendal nerve (group A) at 3 months and 5 bilateral division of the S2 somatic contribution to the pudendal nerve (group B). The effects of these 2 types of neurotomy on the bladder and urethral responses to electrostimulation were compared after another 3 months. In group A, the proximal and midurethral responses decreased significantly [69.1 % (p = 0.004) and 79.6% (p = 0.002), respectively]. A decrease in bladder response [26% (p = 0.089)], although not significant, was also found. In group B, the decrease in the proximal urethral response was significant [67.8% (p = 0.012)]; the midurethral response (56.8%) was not statistically significant (p = 0.134). The bladder response decreased by 73.6% (p = 0.034). Thus, although pudendal neurotomy can be effective in reducing the outlet resistance, the pudendal nerve may have an important role in the regulation of micturition in the dog. Preoperative testing of the effect of a pudendal neurotomy by temporary nerve blocks is warranted to avoid undesirable side effects such as a decrease in bladder excitability.
ISSN:0042-1138
DOI:10.1159/000282296
出版商:S. Karger AG
年代:1992
数据来源: Karger
|
|